4//SEC Filing
Jones Jeffrey Alan 4
Accession 0000899243-22-008730
CIK 0001789972other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 7:05 PM ET
Size
5.8 KB
Accession
0000899243-22-008730
Insider Transaction Report
Form 4
Jones Jeffrey Alan
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-28+215,000→ 215,000 totalExercise: $14.34Exp: 2032-02-27→ Common Stock (215,000 underlying)
Footnotes (1)
- [F1]The option represents a right to purchase a total of 215,000 shares of the Issuer's Common Stock, 25% of which will become fully vested and exercisable on February 28, 2023, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Documents
Issuer
Cullinan Oncology, Inc.
CIK 0001789972
Entity typeother
Related Parties
1- filerCIK 0001914647
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 7:05 PM ET
- Size
- 5.8 KB